Excision BioTherapeutics Inc — Form D
Excision BioTherapeutics Inc of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-03. The offering totals $10.5M, of which $10.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-03-03
- Form: D
- Accession: 0001847173-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.5M
- Amount sold: $10.5M
- Minimum investment: $1
- Investors: 6
- Date of first sale: 2021-02-16
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-391112
Issuer
- Name: Excision BioTherapeutics Inc
- CIK: 0001847173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 988 MARKET STREET, SECOND FLOOR, SAN FRANCISCO, CA, 94102
- Phone: (404) 229-1162
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Vasudev Bailey | Director | New Yoprk City, NY |
| William Carson | Director | Oakland, CA |
| Daniel Dornbusch | Director | San Francisco, CA |
| Ashok Krishnamurthi | Director | San Francisco, CA |
| Daniel Dornbusch | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More